COVID-19 Vaccine IgG Rapid Test

The COVID-19 Vaccine IgG Rapid Test is a lateral flow immunoassay intended for the qualitative detection of antibodies binding to the Receptor Binding Domain (RBD) of the spike protein of the SARS-CoV-2 virus or COVID-19 vaccine in human serum, plasma or whole blood. The kit is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection, or as an aid in assessing the immune response of individuals that have been previously immunized with a COVID-19 vaccine.